FRI0508 Experience with Interleukin-1 Inhibitor Canakinumab in Auto-Inflammatory Diseases and Systemic Juvenile Idiopathic Arthritis in Clinical Practice
FRI0508 Experience with Interleukin-1 Inhibitor Canakinumab in Auto-Inflammatory Diseases and Systemic Juvenile Idiopathic Arthritis in Clinical Practice